Automakers, Cisco and KKR Headline Busy Week
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Monday kicks off a packed reporting schedule. KKR posts Q3 results before the open on Monday, with private equity investors watching fee-related earnings closely after a strong dealmaking year.
SoftBank Group reports Tuesday, giving markets a fresh read on its Vision Fund portfolio valuations. The Japanese tech conglomerate's results arrive as AI investment sentiment stays elevated.
Wednesday is the main event. Cisco Systems releases Q1 fiscal 2027 numbers after the close. Analysts want clarity on enterprise AI networking demand. The stock has tracked broader tech momentum this year.
Also Wednesday, London-listed private equity firm 3i Group posts first-half results.
The automotive sector dominates Thursday. Honda Motor reports, with ORTEX alt data showing Japanese car registrations running 6% above the same quarter last year, a dataset with a strong historical fit for Honda revenue. Polestar also reports Thursday. Dutch car registrations, a leading indicator for Polestar revenue, are tracking 68% below year-ago levels, a sharp contrast to the broader European picture.
No IPOs are scheduled in the next seven days.
Index watchers have one more focal point. The MSCI World November Quarterly Review announces Wednesday. ORTEX Index Rebalance Radar forecasts around eight deletions, with Moderna carrying an 88% addition probability and an estimated $6.4 billion of forced buying.
The macro backdrop is firm. US nonfarm payrolls hit 159,293 thousand in October, the largest October reading since 1997, with average hourly earnings rising to $38.00, a record for the month since 2006.
Stocks in this article
How this article was generated
- Generated
- 7 Nov 2026, 20:31
- Prompt version
- v1.0
- Data sources
- EarningsAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.